Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 112 citing Pistrosch: Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction,.... (0.10 sec) 

Protection of the kidney by thiazolidinediones: an assessment from bench to …


PA Sarafidis, GL Bakris - Kidney international, 2006 - nature.com
The global epidemic of diabetes mellitus has led to a continuous increase in the prevalence
of diabetic nephropathy over the past years. Thus, diabetic nephropathy is currently the number
one cause of end-stage renal disease in the Western world. It represents a major public ...
Cited by 72 - Related articles - BL Direct - All 4 versions

Time to abandon microalbuminuria?


P Ruggenenti, G Remuzzi - Kidney international, 2006 - nature.com
The term microalbuminuria – a urinary albumin excretion (UAE) between 20 and 200 g/min –
has been introduced to identify subjects at increased risk of renal and cardiovascular
disease. However, the relationship between albuminuria and risk is not restricted to the ...
Cited by 54 - Related articles - BL Direct - All 7 versions

Endothelial dysfunction in diabetes mellitus

- nih.gov
M Chakir, GE Plante - Prostaglandins, Leukotrienes & Essential Fatty Acids, 1996 - Elsevier
In the present study, we examined the pattern of Evan's blue (EB) extravasation over time and
we verified the effect of two inhibitors of aldose reductase (sorbinil and ARI 509) as well as
aminoguanidine, which modulate nitric oxide (NO) production, on streptozotocin-induced ...
Cited by 35 - Related articles - BL Direct - All 12 versions

Peroxisome proliferator-activated receptor gamma agonists in renal disease

- eje.org
P Iglesias, JJ Diez - European Journal of Endocrinology, 2006 - eje.org
Type 2 diabetes is a well recognised cause of chronic renal failure (CRF). Only few oral antidiabetic
drugs can be used for treating type 2 diabetes in patients with CRF. Among them are
repaglinide, a rapid-acting prandial insulin releaser, and peroxisome ...
Cited by 25 - Related articles - BL Direct - All 7 versions

Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the …

- critcaremed.org
C Zoccali - Journal of hypertension, 2006 - journals.lww.com
The endogenous inhibitor of the nitric oxide synthase, asymmetric dimethylarginine (ADMA),
by reducing nitric oxide (NO) availability, may trigger pro-atherogenic effects. A high plasma
concentration of this substance has been associated to intima-media thickening, left ...
Cited by 24 - Related articles - BL Direct - All 10 versions

Pleiotropic effects of thiazolidinediones


CV Rizos, EN Liberopoulos, DP … - Expert Opin. …, 2008 - informahealthcare.com
Background: Insulin resistance and hyperglycemia characterize type 2 diabetes mellitus. Type
2 diabetes mellitus is usually accompanied by concomitant disorders, such as dyslipidemia,
hypertension and atherosclerosis. Thiazolidinediones are antidiabetic drugs that increase ...
Cited by 18 - Related articles - BL Direct - All 6 versions

Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory …

- oxfordjournals.org
GJ Ko, YS Kang, SY Han, MH Lee, HK Song, KH … - Nephrology Dialysis …, 2008 - ERA-EDTA
Results. Treatment of OLETF rats with pioglitazone improved insulin sensitivity and kidney/body
weight, but had a little effect on blood pressure. Pioglitazone treatment markedly reduced urinary
albumin and MCP-1 excretion, and ameliorated glomerulosclerosis. In cDNA microarray ...
Cited by 14 - Related articles - All 4 versions

Heart failure and nephropathy: catastrophic and interrelated complications of …

- asnjournals.org
RE Gilbert, K Connelly, DJ Kelly, CA Pollock, … - Clinical Journal of the …, 2006 - Am Soc Nephrol
Heart failure (HF) is a major contributor to poor quality of life, a leading cause of
hospitalization, and cause of premature death. Both kidney disease and diabetes are major and
independent risk factors for the development of heart failure, such that individuals with ...
Cited by 15 - Related articles - BL Direct - All 5 versions

Thiazolidinediones provide better renoprotection than insulin in an obese, …


S Ohtomo, Y Izuhara, S Takizawa, N Yamada, T … - Kidney international, 2007 - nature.com
Hyperinsulinemia has been implicated in the development of diabetic nephropathy. In the present
study we compared the renoprotective effects of the thiazolidinedione, pioglitazone (PGZ), to
that of insulin in a hypertensive, obese, type II diabetic rat model. PGZ aggravated obesity ...
Cited by 13 - Related articles - BL Direct - All 5 versions

Dual Peroxisome Proliferator-Activated Receptor-[alpha]/[gamma] Agonists: In the …

- critcaremed.org
HA Pershadsingh - Treatments in Endocrinology, 2006 - pt.wkhealth.com
Peroxisome proliferator-activated receptors (PPARs) are relatively recently discovered nuclear
transcription factors that are modulated by dietary fatty acids, including the essential polyunsaturated
fatty acids, arachidonic acid and its metabolites, and are essential to the control of energy ...
Cited by 11 - Related articles - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google